loading
前日終値:
$5.37
開ける:
$5.17
24時間の取引高:
679.62K
Relative Volume:
0.17
時価総額:
$7.95M
収益:
-
当期純損益:
$-5.73M
株価収益率:
-0.8244
EPS:
-6.55
ネットキャッシュフロー:
$-4.13M
1週間 パフォーマンス:
+31.01%
1か月 パフォーマンス:
-13.90%
6か月 パフォーマンス:
+32.60%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$4.5421
$5.7478
1週間の範囲:
Value
$3.44
$7.73
52週間の値動き範囲:
Value
$1.62
$29.28

Dogwood Therapeutics Inc Stock (DWTX) Company Profile

Name
名前
Dogwood Therapeutics Inc
Name
セクター
Healthcare (1155)
Name
電話
(866) 620-8655
Name
住所
44 MILTON AVENUE, ALPHARETTA
Name
職員
12
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
DWTX's Discussions on Twitter

DWTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DWTX
Dogwood Therapeutics Inc
5.45 7.95M 0 -5.73M -4.13M -6.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.40 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.35 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.91 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.34 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
253.34 26.16B 3.81B -644.79M -669.77M -6.24

Dogwood Therapeutics Inc (DWTX) 最新ニュース

pulisher
11:03 AM

Dogwood Therapeutics Inc (NASDAQ: DWTX) Has Been Trading Down. What Are The Prospects For The Future? - Stocksregister

11:03 AM
pulisher
08:47 AM

You might want to take a look at Dogwood Therapeutics Inc (DWTX) now - Sete News

08:47 AM
pulisher
Apr 21, 2025

You Should Read This Analysis Before Investing in Dogwood Therapeutics Inc (NASDAQ:DWTX) - uspostnews.com

Apr 21, 2025
pulisher
Apr 15, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Dogwood Therapeutics (DWTX) Begins Phase 2b Trial for Halneuron - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Dogwood Therapeutics (DWTX) Regains Nasdaq Compliance - GuruFocus

Apr 15, 2025
pulisher
Apr 12, 2025

Dogwood Therapeutics (DWTX) Regains Nasdaq Compliance with Equit - GuruFocus

Apr 12, 2025
pulisher
Apr 11, 2025

Dogwood Therapeutics regains Nasdaq compliance By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 11, 2025

Dogwood Therapeutics regains Nasdaq compliance - Investing.com

Apr 11, 2025
pulisher
Apr 11, 2025

Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation Of Compliance - marketscreener.com

Apr 11, 2025
pulisher
Apr 11, 2025

Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance - GlobeNewswire

Apr 11, 2025
pulisher
Apr 11, 2025

Nasdaq Delisting Risk Eliminated: Dogwood Therapeutics Secures Future with $17.5M War Chest - Stock Titan

Apr 11, 2025
pulisher
Apr 09, 2025

Sodium Channel Blockers Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.

Apr 09, 2025
pulisher
Apr 04, 2025

DWTX: Interim Data for Phase 2b Trial in 4Q25… - Yahoo Finance

Apr 04, 2025
pulisher
Apr 04, 2025

Dogwood Therapeutics regains compliance with Nasdaq - MSN

Apr 04, 2025
pulisher
Apr 03, 2025

Dogwood Therapeutics Announces Nasdaq Compliance Regained - Nasdaq

Apr 03, 2025
pulisher
Apr 03, 2025

Dogwood Therapeutics, Inc. Regains Nasdaq Compliance - GlobeNewswire

Apr 03, 2025
pulisher
Apr 01, 2025

Dogwood Therapeutics Reports 2024 Financial Results and Strategic Progress - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Dogwood Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Dogwood Strengthens Balance Sheet with $24M Capital Actions as Halneuron Trial Progresses - Stock Titan

Mar 31, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics begins Phase 2b trial for neuropathic pain By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

DWTX: First Patient Dosed in Phase 2b Trial of Halneuron in CINP; Debt Conversion Strengthens Balance Sheet… - Zacks Small Cap Research

Mar 18, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics Begins Dosing in Mid-Stage Study of Halneuron for Chemotherapy-Related Neuropathic Pain - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics begins Phase 2b trial for neuropathic pain - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Dogwood Therapeutics Announces Dosing of First Patient in - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Revolutionary Non-Addictive Pain Treatment Enters Critical Phase 2b Trial for Cancer Patients - StockTitan

Mar 18, 2025
pulisher
Mar 14, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics announces pricing of $4.8 million offering - MSN

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics Launches Registered Direct Offering; Shares Plunge -March 13, 2025 at 09:40 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics secures $4.8 million in direct offering By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics secures $4.8 million in direct offering - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics Secures $4.8 Million in Direct Offering to Advance Halneuron® Phase 2b Trial and Fund Operations Through Q1 2026 - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics, Inc. Announces Pricing of $4.8 - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Secures Critical Funding for Revolutionary Pain Treatment: What's Next for Halneuron? - StockTitan

Mar 13, 2025
pulisher
Mar 13, 2025

Dogwood Therapeutics Announces Pricing Of $4.8 Million Registered Direct Offering Of Common Stock Priced At-The-Market Under Nasdaq Rules - marketscreener.com

Mar 13, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics clears debt with equity swa By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics converts existing debt to equity -March 12, 2025 at 10:34 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics Strengthens Balance Sheet with Debt Conversion - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics clears debt with equity swa - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics Announces Debt-to-Equity Exchange with CK Life Sciences, Strengthening Financial Position for Clinical Trials - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward - Financial Post

Mar 12, 2025
pulisher
Mar 12, 2025

Dogwood Therapeutics, Inc. Announces Conversion of Existing - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Major Breakthrough: Dogwood Therapeutics Wipes Out All Debt as Top Investor Backs Pain Drug Future - StockTitan

Mar 12, 2025
pulisher
Feb 27, 2025

Dogwood Therapeutics (DWTX) to Release Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 24, 2025

Dogwood Therapeutics Inc expected to post a loss of $1.41 a shareEarnings Preview - TradingView

Feb 24, 2025
pulisher
Feb 18, 2025

DWTX Stock Hits 52-Week High at $15.74 Amidst Strong Yearly Growth - MSN

Feb 18, 2025
pulisher
Feb 04, 2025

Closing Figures Unveiled: Dogwood Therapeutics Inc (DWTX) Gain 13.53, Closes at 14.18 - The Dwinnex

Feb 04, 2025
pulisher
Jan 28, 2025

Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Surge - MSN

Jan 28, 2025
pulisher
Jan 27, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Jan 27, 2025
pulisher
Jan 27, 2025

Stock market news: Planet Image International +132.83%, Akero Therapeutics +94.04% among top gainers during mid day trading - Business Upturn

Jan 27, 2025

Dogwood Therapeutics Inc (DWTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$19.80
price down icon 1.75%
$70.30
price up icon 2.22%
$32.51
price up icon 0.87%
$26.24
price up icon 1.84%
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
大文字化:     |  ボリューム (24 時間):